	Ventes		Date
AbbVie	USD 16.62B	840M	2025-12
Alcon AG	USD 2.59B	10M	2025-09
Almirall	EUR 560.46M	71.95M	2025-06
Amgen	USD 9.9B	340M	2025-12
argenx SE	USD 987.09M	144.59M	2025-09
AstraZeneca	USD 15.5B	313M	2025-12
Bayer	EUR 9.66B	1.08B	2025-09
Biogen	USD 2.28B	250M	2025-12
Bristol-Myers Squibb	USD 12.5B	300M	2025-12
Eli Lilly	USD 19.3B	1.7B	2025-12
Fresenius	EUR 5.48B	100M	2025-09
Fresenius Medical Care	EUR 4.89B	100M	2025-09
Galapagos	EUR 65.3M	4.87M	2025-09
Genmab	DKK 5.86B	580M	2025-06
Gilead Sciences	USD 7.93B	130M	2025-12
GlaxoSmithKline	GBP 8.62B	73M	2025-12
Glaxosmithkline	GBP 11.52B	3.54B	2025-09
GRIFOLS	EUR 1.87B	20M	2025-09
Hikma Pharmaceutical	USD 829M	758M	2025-06
Lonza	CHF 3.58B	63M	2025-06
Merck	EUR 5.32B	890M	2025-09
Merck	USD 16.4B	880M	2025-12
Novartis	USD 13.91B	144M	2025-09
Novo Nordisk	DKK 79.14B	4.16B	2025-12
Orion	EUR 695.3M	272.1M	2025-12
Pfizer	USD 17.58B	880M	2025-12
Philips	EUR 5.1B	797M	2025-12
Recordati	EUR 662M	37.65M	2025-12
Regeneron Pharmaceuticals	USD 3.88B	130M	2025-12
Roche Holding	CHF 15.65B	274.5M	2025-12
Sanofi	EUR 11.3B	1.13B	2025-12
Smith & Nephew	USD 2.96B	134M	2025-12
UCB	EUR 3.49B	129M	2025-06

GlaxoSmithKline Ventes - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Feb 2026.